BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31914402)

  • 21. USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.
    Perry M; Biegert M; Kollala SS; Mallard H; Su G; Kodavati M; Kreiling N; Holbrook A; Ghosal G
    J Biol Chem; 2021; 296():100396. PubMed ID: 33567341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
    Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
    Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRL4
    Huang D; Liu C; Sun X; Sun X; Qu Y; Tang Y; Li G; Tong T
    Biochem Biophys Res Commun; 2020 Aug; 529(2):127-132. PubMed ID: 32703400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury.
    Zhao J; Wei J; Dong S; Bowser RK; Zhang L; Jacko AM; Zhao Y
    EBioMedicine; 2016 Aug; 10():195-203. PubMed ID: 27448760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).
    Yamaguchi T; Kimura J; Miki Y; Yoshida K
    J Biol Chem; 2007 Nov; 282(47):33943-8. PubMed ID: 17897950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionine and leucine induce ARID1A degradation to promote mTOR expression and milk synthesis in mammary epithelial cells.
    Qi H; Wang L; Zhang M; Wang Z; Gao X; Li M
    J Nutr Biochem; 2022 Mar; 101():108924. PubMed ID: 34843932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM32 promotes oral squamous cell carcinoma progression by enhancing FBP2 ubiquitination and degradation.
    Yang X; Ma H; Zhang M; Wang R; Li X
    Biochem Biophys Res Commun; 2023 Oct; 678():165-172. PubMed ID: 37640002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
    Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
    Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.
    Borlepawar A; Rangrez AY; Bernt A; Christen L; Sossalla S; Frank D; Frey N
    J Biol Chem; 2017 Jun; 292(24):10180-10196. PubMed ID: 28465353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
    Cai Y; Gu WT; Cheng K; Jia PF; Li F; Wang M; Zhang WF; Qiu JT; Wu ZB; Zhao WG
    Biochem Biophys Res Commun; 2021 Apr; 550():134-141. PubMed ID: 33691199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.
    Liu J; Zhang C; Wang XL; Ly P; Belyi V; Xu-Monette ZY; Young KH; Hu W; Feng Z
    Cell Death Differ; 2014 Nov; 21(11):1792-804. PubMed ID: 25146927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homeostatic scaling is driven by a translation-dependent degradation axis that recruits miRISC remodeling.
    Srinivasan B; Samaddar S; Mylavarapu SVS; Clement JP; Banerjee S
    PLoS Biol; 2021 Nov; 19(11):e3001432. PubMed ID: 34813590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
    Wang J; Fang Y; Liu T
    Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
    Yoo L; Yoon AR; Yun CO; Chung KC
    Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway.
    Sun H; Ou B; Zhao S; Liu X; Song L; Liu X; Wang R; Peng Z
    EBioMedicine; 2019 Oct; 48():236-247. PubMed ID: 31521612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM.
    Ideguchi H; Ueda A; Tanaka M; Yang J; Tsuji T; Ohno S; Hagiwara E; Aoki A; Ishigatsubo Y
    Biochem J; 2002 Oct; 367(Pt 1):87-95. PubMed ID: 12084015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory feedback loop between TP73 and TRIM32.
    Gonzalez-Cano L; Hillje AL; Fuertes-Alvarez S; Marques MM; Blanch A; Ian RW; Irwin MS; Schwamborn JC; Marín MC
    Cell Death Dis; 2013 Jul; 4(7):e704. PubMed ID: 23828567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of peptide ligands targeting a specific ubiquitin-like domain-binding site in the deubiquitinase USP11.
    Spiliotopoulos A; Blokpoel Ferreras L; Densham RM; Caulton SG; Maddison BC; Morris JR; Dixon JE; Gough KC; Dreveny I
    J Biol Chem; 2019 Jan; 294(2):424-436. PubMed ID: 30373771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP11 regulates p53 stability by deubiquitinating p53.
    Ke JY; Dai CJ; Wu WL; Gao JH; Xia AJ; Liu GP; Lv KS; Wu CL
    J Zhejiang Univ Sci B; 2014 Dec; 15(12):1032-8. PubMed ID: 25471832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.